Experimental injection aims to tame dangerous blood fats

NCT ID NCT04832971

Completed Disease control Sponsor: Arrowhead Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether an investigational drug called ARO-ANG3, given as injections under the skin, could safely lower unhealthy levels of fats in the blood (mixed dyslipidemia). It involved 204 adults who were already on stable cholesterol medication. Participants received either the real drug or a placebo for 24 weeks, with an option to continue receiving the drug in a follow-up period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site 1

Marion, Ohio, 43302, United States
Research Site 10

Omaha, Nebraska, 68114, United States
Research Site 11

Houston, Texas, 77030, United States
Research Site 12

Québec, G1G 3Z4, Canada
Research Site 13

Christchurch, 8011, New Zealand
Research Site 14

Rotorua, 3010, New Zealand
Research Site 15

Greensboro, North Carolina, 27408, United States
Research Site 16

Chicoutimi, Quebec, G7H 7K9, Canada
Research Site 17

Miami, Florida, 33144, United States
Research Site 18

Nedlands, 6009, Australia
Research Site 19

Birkenhead, 0626, New Zealand
Research Site 2

Morehead City, North Carolina, 28557, United States
Research Site 20

Hamilton, 3200, New Zealand
Research Site 21

Sippy Downs, Queensland, 4556, Australia
Research Site 22

New York, New York, 10029, United States
Research Site 23

Las Vegas, Nevada, 89121, United States
Research Site 24

Minneapolis, Minnesota, 55455, United States
Research Site 25

London, Ontario, N6A 5A5, Canada
Research Site 4

Camp Hill, Pennsylvania, 17011, United States
Research Site 5

Huntington Park, California, 90255, United States
Research Site 6

Blacktown, New South Wales, 2148, Australia
Research Site 7

Hialeah, Florida, 33012, United States
Research Site 8

Port Orange, Florida, 32127, United States
Research Site 9

Québec, H7T2P5, Canada

Conditions

Explore the condition pages connected to this study.

MIXED DYSLIPIDEMIA